New treatment regimen could extend blood cancer remission by seven months

An innovative blood cancer treatment regimen could extend remission by seven months on average, according to a clinical trial led by the University of Leeds.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup